Novotech
Fred Cohen is a Senior Advisor to TPG and was a Partner and co-founder of TPG Biotechnology. Fred has served on the Board of several biotech and pharmaceutical organizations including Biocryst (BCRX), CareDx (CDNA), and is a co-founder of Sweetwater Spectrum, a non-profit autism support organization.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Novotech
5 followers
Novotech is internationally recognized as the leading regional full-service contract research organization (CRO). Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials in the Asia Pacific region.